Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChina Pacific Regulatory News (CPIC)

Share Price Information for China Pacific (CPIC)

Share Price is delayed by 15 minutes
Get Live Data
26.60    0.00 (0.00%)
Bid:
23.20
Ask:
24.20
Spread: 1.00 (4.31%)
Market Cap: $51.18b
CPIC Live PriceLast checked at - London Stock Exchange

Intraday China Pacific Share Chart

  • This share is an international stock.

Announcement relating to election and appointment

29 Feb 2024 14:09

RNS Number : 0201F
China Pacific Insurance Grp Co. Ltd
29 February 2024
 

29 February 2024

CHINA PACIFIC INSURANCE (GROUP) CO., LTD.

(A joint stock company incorporated in the People's Republic of China with limited liability)

Election of Directors and Shareholder Representative Supervisors, Appointment of Chairman and Vice Chairman of The Board of Directors, President and the Members of the Special Committees of the 10th Session of the Board of Directors

Reference is made to the announcement on the poll results of the extraordinary general meeting (the "EGM") of China Pacific Insurance (Group) Co., Ltd. (the "Company") dated 29 February 2024.

ELECTION OF DIRECTORS OF THE 10TH SESSION OF THE BOARD OF DIRECTORS

Through the votes of the shareholders of the Company at the EGM, the election and re-election of all the director candidates of the 10th session of the board of directors of the Company (the "Board of Directors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of each of Mr. FU Fan, Mr. HUANG Dinan, Mr. WANG Tayu, Mr. CHEN Ran, Mr. ZHOU Donghui, Ms. LU Qiaoling, Mr. John Robert DACEY, Ms. LIU Xiaodan, Ms. LAM Tyng Yih, Elizabeth, Ms. LO Yuen Man, Elaine, Mr. CHIN Hung I David and Mr. JIANG Xuping as a director of the 10th session of the Board of Directors took effect on the date of the EGM. The appointment qualification of Mr. ZHAO Yonggang is still subject to the approval by the National Administration of Financial Regulation (the "NAFR").

The biographical details of the above directors were set out in the notice of the Company dated 5 February 2024.

The term of office of Mr. WU Junhao, being a director of the 9th session of the Board of Directors, has expired. The Company would like to thank Mr. WU Junhao for his contributions to the Company made during his period of service.

ELECTION OF SHAREHOLDER REPRESENTATIVE SUPERVISORS OF THE 10TH SESSION OF THE BOARD OF SUPERVISORS

Through the votes of shareholders of the Company at the EGM, the election and re-election of all the shareholder representative supervisor candidates of the 10th session of the board of supervisors of the Company (the "Board of Supervisors") were duly approved by the shareholders of the Company. According to the relevant regulatory requirements, the appointment of Mr. ZHU Yonghong as a shareholder representative supervisor of the 10th session of the Board of Supervisors took effect on the date of the EGM. The appointment of Mr. YUE Lin is still subject to the approval by the NAFR.

The biographical details of the above supervisors were set out in the notice of the Company dated 5 February 2024.

The term of office of Mr. LU Ning, being a shareholder representative supervisor of the 9th session of the Board of Supervisors, has expired. The Company would like to thank Mr. LU Ning for his contributions to the Company made during his period of service.

Until the completion of the election of the new session of the Board of Supervisors, the ninth session of the Board of Supervisors is still required to perform its duties in accordance with relevant laws and regulations as well as the provisions of the Articles of Association.

APPOINTMENT OF CHAIRMAN, VICE CHAIRMAN OF THE BOARD OF DIRECTORS AND PRESIDENT

The Company is pleased to announce that the first meeting of the 10th session of the Board of Directors was held on 29 February 2024. At the meeting, Mr. FU Fan was elected as the Chairman of the Board of Directors, Mr. HUANG Dinan was elected as the Vice Chairman of the Board of Directors, and Mr. ZHAO Yonggang was appointed as President.

APPOINTMENT OF THE MEMBERS OF THE SPECIAL COMMITTEES OF THE 10TH SESSION OF THE BOARD OF DIRECTORS

The Board of Directors herby announces that the Audit Committee has been renamed to Audit and Related Party Transaction Control Committee and Risk Management and Related Party Transaction Control Committee has been renamed to Risk Management Committee.

The 10th session of the Board of Directors has five committees, namely the Strategic and Investment Decision-Making & ESG Committee, the Audit and Related Party Transaction Control Committee, the Nomination and Remuneration Committee, the Risk Management Committee and the Technological Innovation and Consumer Rights Protection Committee. The composition of each committee is as follows:

Strategic and Investment Decision-Making & ESG Committee

Chairman: FU Fan (Executive Director)

Other members: CHIN Hung I David (Independent Non-executive Director)

HUANG Dinan (Non-executive Director)

LU Qiaoling (Non-executive Director)

John Robert DACEY (Non-executive Director)

Audit and Related Party Transaction Control Committee

Chairman: LAM Tyng Yih, Elizabeth (Independent Non-executive Director)

Other members: LO Yuen Man, Elaine (Independent Non-executive Director)

ZHOU Donghui (Non-executive Director)

JIANG Xuping (Independent Non-executive Director)

Nomination and Remuneration Committee

Chairman: LIU Xiaodan (Independent Non-executive Director)

Other members: WANG Tayu (Non-executive Director)

CHIN Hung I David (Independent Non-executive Director)

JIANG Xuping (Independent Non-executive Director)

Risk Management Committee

Chairman: ZHAO Yonggang (Executive Director)

Other members: WANG Tayu (Non-executive Director)

LAM Tyng Yih, Elizabeth (Independent Non-executive Director)

LO Yuen Man, Elaine (Independent Non-executive Director)

Technological Innovation and Consumer Rights Protection Committee

Chairman: JIANG Xuping (Independent Non-executive Director)

Other members: CHEN Ran (Non-executive Director)

ZHOU Donghui (Non-executive Director)

ZHAO Yonggang (Executive Director)

 

 

 

 

By Order of the Board of Directors

China Pacific Insurance (Group) Co., Ltd.

FU Fan

Chairman

 

 

About CPIC

CPIC is a joint stock company established under the laws of the People's Republic of China with limited liability.

CPIC's registered office is located at 1 South Zhongshan Road, Huangpu District, Shanghai, the People's Republic of China.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEALANAEPLEFA
Date   Source Headline
10th Jun 20261:34 pmRNSPoll results for the 2025 AGM
8th Jun 202612:30 pmRNSApproval of Director's Appointment Qualification
26th May 202611:05 amRNSAppointment of Vice President
20th May 202610:26 amRNSNotice of the 2025 Annual General Meeting
30th Apr 20269:50 amRNSDirector/PDMR Shareholding
28th Apr 202610:48 amRNSPublication of Summaries of Solvency Reports
28th Apr 202610:36 amRNS2026 First Quarter Report
22nd Apr 202610:35 amRNS2025 Sustainability Report
21st Apr 202611:10 amRNS2026 Q1 Results Presentation
14th Apr 202610:07 amRNSPDMR Shareholding
26th Mar 202612:32 pmRNSPublication of Annual Results Presentation
26th Mar 202612:22 pmRNSPublication of Summaries of Solvency Reports
26th Mar 202612:16 pmRNSCPIC 2025 Annual Report
18th Mar 20269:40 amRNSConvening of 2025 Annual Results Presentation
26th Jan 202611:16 amRNSApproval of Director's Appointment Qualification
19th Jan 20269:35 amRNSAnnouncement relating to Premium Income
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
23rd Dec 202512:55 pmRNSApproval of AoA and Dissolution of the BOS
16th Dec 20259:17 amRNSAnnouncement relating to Premium Income
9th Dec 202510:10 amRNSRelevant presentations on 2025 investor day
4th Dec 20259:58 amRNSApproval of Director's Appointment Qualification
27th Nov 20259:06 amRNSDirector Shareholding
21st Nov 20259:10 amRNSElection of Employee Director
13th Nov 20259:11 amRNSAnnouncement relating to Premium Income
30th Oct 202511:02 amRNSSummaries of the Quarterly Solvency Reports
30th Oct 20259:54 amRNS2025 Third Quarter Report
21st Oct 202510:41 amRNS2025 Q3 Results Presentation
16th Oct 202511:36 amRNSAnnouncement relating to Premium Income
19th Sep 20257:00 amRNSPublication of Offering Circular of Bonds
18th Sep 202510:51 amRNSAnnouncement relating to Premium Income
18th Sep 202510:43 amRNSCompletion of the Issue of Convertible Bonds
18th Sep 202510:40 amRNSNotice of Listing of Convertible Bonds
11th Sep 20257:00 amRNSProposed issue of Bonds under General Mandate
10th Sep 202512:24 pmRNSProposed issue of Convertible Bonds
29th Aug 202512:35 pmRNSAnnouncement on Poll Results for the EGM
28th Aug 20252:24 pmRNSResignation of Supervisor
28th Aug 20251:25 pmRNSPublication of Summaries of Solvency Reports
28th Aug 20251:24 pmRNSPublication of 2025 Interim Results Presentation
28th Aug 20251:17 pmRNS2025 Interim Report
21st Aug 202511:47 amRNSConvening of 2025 Interim Results Presentation
13th Aug 202510:50 amRNSAnnouncement relating to Premium Income
11th Aug 202511:21 amRNSNotice of EGM
30th Jul 20254:01 pmRNSAmendments to the AoA and dissolution of the BOS
15th Jul 202511:23 amRNSAnnouncement relating to Premium Income
24th Jun 202510:23 amRNSResignation of Director of the Board
13th Jun 202510:15 amRNSAnnouncement relating to Premium Income
11th Jun 202512:58 pmRNSPoll Results for the 2024 AGM
6th Jun 202510:48 amRNSApproval of Appointment Qualification
21st May 202511:19 amRNSNotice of the 2024 Annual General Meeting
14th May 202511:30 amRNSAnnouncement relating to Premium Income

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.